Marti-Marca, Angela
Vilà-Balló, Adrià
Cerda-Company, Xim
Ikumi, Nara
Torres-Ferrus, Marta
Caronna, Edoardo
Gallardo, Victor J.
Alpuente, Alicia
Torralba Cuello, Mireia
Soto-Faraco, Salvador
Pozo-Rosich, Patricia
Funding for this research was provided by:
Fundació Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR/BEQUESPREDOC/2020/MARTI)
Ministerio de Ciencia e Innovación (FJC2018-036804-I, PID2019-108531GB-I00 AEI/FEDER)
European Regional Development Fund (001-P-001682)
Instituto de Salud Carlos III (CM20/00217)
Generalitat de Catalunya (2017 SGR 1545)
“la Caixa” Foundation (LCF/PR/PR16/51110005)
Article History
Received: 10 March 2023
Accepted: 20 June 2023
First Online: 7 August 2023
Declarations
:
: Both experiments were approved by the Ethics Committee at the Vall d’Hebron Hospital (Experiment 1: PR(AG) 376/2017), Experiment 2: EudraCT 2019–002224-32). Participants in both experiments provided their informed written consent and received monetary compensation. In Experiment 1, all participants received 25 euros upon completion and in Experiment 2 headache-free controls received 35 euros as compensation whereas patients were administered preventive treatment.
: Not applicable.
: The authors declare no competing interests.